131I治疗分化型甲状腺癌患者唾液腺损伤的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Damage of salivary gland function induced by 131I treatment in patients with differentiated thyroid carcinoma
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:了解分化型甲状腺癌(differentiated thyroid carcinoma,DTC)的患者经大剂量131I治疗后,慢性唾液腺损伤的发病情况-方法:143例分化型甲状腺癌的患者经手术切除后行大剂量的131I治疗,在131I治疗前和治疗后的6~39个月随访中分别行唾液腺功能显像-结果:143例DTC患者中有31例(21.7%)出现慢性唾液腺损伤,131I治疗2次以上(累积剂量7.4~37.0 GBq)发生慢性唾液腺损伤的发病率明显高于131I治疗1次者(累积剂量<3.7 GBq)(P < 0.005)-结论:反复的-大剂量131I治疗引起的慢性唾液腺损伤更多见-

    Abstract:

    Objective:To investigate the chronic function damage of the salivary gland by high dose of 131I in the treatment of differentiated thyroid carcinoma(DTC). Methods:Salivary gland scintigraphy,for function evaluation,were made before and 6~39 months after high dose of 131I treatment on 143 patients with DTC after thyroid ablation. Results:21.7%(31/143)patients with DTC suffered from chronic salivary gland damage after 131I treatment. And the incidence of chromic damage was more predominant in patients received repeated 131I therapy(aggregated dose ranging from 7.4~37.0 GBq)than those treated with once 131I therapy(dose less than 3.7 GBq).(P < 0.005). Conclusion:Repeating and large dose of 131I treatment is more common in the causes of chronic salivary gland damage.

    参考文献
    相似文献
    引证文献
引用本文

李少华,王自正,王〓峰,姚薇萱,邵国强,蒋〓娥,张乐乐,孟庆乐.131I治疗分化型甲状腺癌患者唾液腺损伤的影响[J].南京医科大学学报(自然科学版),2010,(7):998-1001

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2010-01-05
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期:
通知关闭
郑重声明